IVERIC bio, Inc.

JPMORGAN CHASE & CO

Report date

6/30/2023

Quarter

2023 Q2

Filed

8/11/2023

Shares

403,077

Value ($000)

15,857

Weight

0.0%

2020 Q1 - 2023 Q2 (14 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q2	8/11/2023	15,857	0.0%	403,077	6/30/2023
2023 Q1	5/18/2023	19,028	0.0%	782,096	3/31/2023
2022 Q4	2/13/2023	14,967	0.0%	699,093	12/31/2022
2022 Q3	11/14/2022	14,532	0.0%	810,033	9/30/2022
2022 Q2	8/11/2022	8,885	0.0%	923,597	6/30/2022
2022 Q1	5/11/2022	9,120	0.0%	541,865	3/31/2022
2021 Q4	2/11/2022	1,367	0.0%	81,728	12/31/2021
2021 Q3	11/12/2021	751	0.0%	46,269	9/30/2021
2021 Q2	8/12/2021	246	0.0%	39,130	6/30/2021
2021 Q1	5/12/2021	187	0.0%	30,284	3/31/2021
2020 Q4	2/19/2021	247	0.0%	35,729	12/31/2020
2020 Q3	11/12/2020	347	0.0%	64,229	9/30/2020
2020 Q2	8/11/2020	561	0.0%	109,967	6/30/2020
2020 Q1	5/12/2020	59	0.0%	17,273	3/31/2020